摘要:
The invention is directed to droplet actuator devices and assay methods. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate within an aqueous environment in contact with an oil.
摘要:
The present invention relates to sulfonated coumarins, to the synthesis thereof, to fluorogenic substrates resulting from grafting said coumarins onto sugars, to a method for preparing said substrates, and to the uses thereof. The substituted sulfonated coumarins are expressed in general formula (I), where: R 1 is H, OH, or a substituted or unsubstituted, straight or branched C 1 to C 6 alkyl radical, or -COR 4 , -COOR 4 , or -CONHR 4 , R 2 is H or a halogen, in particular fluorine, or a substituted or unsubstituted, straight or branched C 1 to C 6 alkyl radical, or -COR 4 , -COOR 4 , or -CONHR 4 , R 1 and R 2 being capable of together forming a ring, such as a substituted or unsubstituted aryl or furan, R 3 is H or a halogen, particularly fluorine or a substituted or unsubstituted, straight or branched C 1 to C 6 alkyl radical, or -COR 4 , -COOR 4 , or - CONHR 4 , where R 4 is H or a substituted or unsubstituted, straight or branched C 1 to C 6 alkyl radical, or a substituted or unsubstituted aryl, and M is Na or K. The substrates are prepared by grafting said coumarins with the following sugars: cellobiose, xylobiose, maltose, saccharose, glucose, xylose, galactose, arabinose, xylan, glucan, xylotriose, maltotriose, cellotriose, xylotetraose, or a mixture of some of said sugars. The invention is useful in detecting glycosidase (EC3.2.1) activity on purified or unpurified enzyme extracts, or on microorganisms or cells.
摘要:
The invention relates to novel compounds having formula (I) in which: R1, R2 and R3 are identical or different and each represent independently: - a (C1-C6)alkyl group, - a pyridinyl group, or a -CH2-NR4R5 group in which R4 and R5 each represent independently a hydrogen atom, a (C1-C4)alkyl group or R4 and R5 form, together with the nitrogen atom to which they are linked, a pyrrolidinyl, piperidinyl, hexahydroazepinyl, morpholinyl or piperazinyl group, provided that at least one of the R1, R2 or R3 substituents is different from the (C1-C6)alkyl group. The invention also relates to the salts, solvates and hydrates thereof, particularly those that are pharmaceutically acceptable. Said compounds are used, in particular, for treating venous circulation problems.
摘要:
The current invention relates to the design, synthesis, and biochemical evaluation of chromogenic substrate compounds for sialidases of bacterial, viral, protozoa, and vertebrate (including human) origin. In particular, this invention provides a novel class of effective compounds as chromogenic substrates of these sialidases which yield chromogenic products after reactions catalyzed by sialidase take place. Also provided are methods of making these substrate compounds, methods of diagnosis and prognosis of sialidase related diseases using these substrate compounds.
摘要:
The invention discloses the compounds of formula (I): R1 = H, OH, alkyl, alkenyl or alkynyl optionally substituted or alkoxy; R2 = H, Hal; R3 = H, alkyl, Hal, R4 = (a) where Rg and Rh are H, alkyl, an aryl heterocycle; R5 = H or O-alkyl; R6 = alkyl or CH2-O-alkyl; R7 = H or alkyl. The compounds of formula (I) have antibiotic properties.
摘要:
The invention concerns compounds of formula (I), in which Y is oxygen, N-Nalc1 or NOalc2; X represents hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkoxy, CONOR or NRcRd, Rc and Rd being hydrogen or alkyl; Z represents hydrogen, halogen or free, etherified or esterified OH; R2 hydrogen or halogen; R3 hydrogen, alkyl or halogen; R hydrogen or alkyl; R1 hydrogen, alkyl, alkenyl or alkynyl; R5 hydrogen or O-alkyl; R6 alkyl or CH2-O-alkyl and R7 hydrogen or alkyl; or R6 and R7 form with the carbon atom which bears them a cyclic radical containing up to 8 carbon atoms. The compounds of formula (I) have antibiotic properties.
摘要:
The invention discloses the compounds of formula (I): R1 = H, OH, alkyl, alkenyl or alkynyl optionally substituted or alkoxy; R2 = H, Hal; R3 = H, alkyl, Hal, R4 = (a) where Rg and Rh are H, alkyl, an aryl heterocycle; R5 = H or O-alkyl; R6 = alkyl or CH2-O-alkyl; R7 = H or alkyl. The compounds of formula (I) have antibiotic properties.